Investigators

Professor Gustavo Duque

Principal Investigator

Prof. Duque MD, PhD, FRACP completed his training in Internal Medicine in Colombia, and then completed a Fellowship in Geriatric Medicine at McGill University in Montreal (Canada). Subsequently, he obtained his PhD. at McGill University in 2003 with a thesis entitled “Molecular Changes of the Aging Osteoblast.” Between 2003 and November 2007, he joined the faculty at McGill University Medical School as a member of the Division of Geriatric Medicine and as Researcher at the Lady Davis Institute for Medical Research. In November 2007, he moved to Australia to join the Faculty as Associate Professor, Head of the Division of Geriatric Medicine, at Sydney Medical School‐Nepean, University of Sydney. In 2012, he was promoted to Professor of Medicine at the University of Sydney. In 2015, he moved to Melbourne to assume the positions of Chair of Medicine and Director of the Australian Institute for Musculoskeletal Science (AIMSS) at the University of Melbourne, and Geriatrician (Staff Specialist) at Western Health. He is the Director of the Falls and Fracture Prevention Program at Western Health, which includes a Fracture Liaison Service, Falls and Fractures Clinic, and the Gait and Balance Gym (Gabagym).

Associate Professor Craig Nelson

Co – Investigator

Assoc. Prof. Nelson MBBS, FRACP, PhD is the Director of Nephrology and Clinical Service Director, Division of Chronic and Complex Care at Western Health in Victoria and Clinical Associate Professor with the North West Academic Centre of the University of Melbourne. He received First Class Honours at Sydney University for his undergraduate medical degree and completed his PhD through the University of Melbourne. He has over 17 years of experience in Nephrology and General Medicine at Royal Melbourne, Northern Health and Western Health. His PhD was completed on novel markers of Cardiovascular Risk in early CKD. His present research interests are in utilising e-Health to improve the detection and management of early CKD and other chronic diseases including Diabetes, Ischaemic Heart Disease, Heart Failure and Stroke.

Professor Mathis Grossmann

Co – Investigator

Prof Grossmann, MD, PhD, FRACP is a physician-scientist trained in biology and in clinical endocrinology. He is Professor of Medicine at the Department of Medicine, University of Melbourne and Austin Health. He also runs the Endocrine Men’s Health and Endocrine Breast Cancer Clinics at Austin Health. His research focuses on the roles of reproductive hormones in health and disease. His group conducts observational and interventional trials in men with i) low testosterone and chronic disease, ii) hypogonadism, iii) prostate cancer receiving androgen deprivation therapy, and iv) women with breast cancer receiving aromatase inhibition to understand how reproductive hormones regulate musculoskeletal health and glucose homeostasis, both at the clinical and the molecular level. He has over 150 peer reviewed publications and book chapters.

Dr Alison Beauchamp

Co – Investigator

Dr Beauchamp, PhD is a health services researcher whose key interests are health literacy and implementation science. She is a NHMRC TRIP Senior Research Fellow at the Department of Medicine ‐ Western Health, The University of Melbourne and the Australian Institute for Musculoskeletal Science (AIMSS) and a Senior Research Fellow at Monash University Department of Rural Health where she supports rural health services to build research capacity. She completed a NHMRC PhD scholarship in social epidemiology at Monash in 2011. Prior to this, she was a Registered Nurse. Between 2013 and 2015 she was ARC post‐doctoral Industry Fellow at Deakin University, where she managed the large Optimising Health Literacy (“Ophelia”) study in which she supported clinicians from 9 health services to plan and deliver health literacy interventions. Dr Beauchamp has 61 peer‐reviewed publications and 3 book chapters.

Associate Professor Sharon Brennan-Olsen

Co – Investigator

Assoc Prof Brennan-Olsen, PhD is Principal Research Fellow with the Department of Medicine-Western Health, University of Melbourne, and Program Director of ‘Population Health’ at the Australian Institute for Musculoskeletal Science (AIMSS). Her research interests are the social determinants of musculoskeletal diseases and related health service utilisation, and biological mechanisms that may underpin the social gradient of musculoskeletal diseases. Her track record includes ~170 peer-reviewed publications, a number of books and book chapters, and ~$4.2million in research funding. She is an active advocate for transparency in science, community engagement, and gender equity.

Associate Professor Peter Hamblin

Co – Investigator

Assoc Prof Hamblin, MBBS, FRACP is Head of Endocrinology & Diabetes at Western Health, Melbourne and a consultant endocrinologist at The Alfred, Melbourne. After graduating from Monash University, he trained in endocrinology & diabetes at The Alfred followed by two years at the University of Minnesota, Minneapolis USA, studying thyroid hormone action. He is an honorary Clinical Associate Professor (Principal Fellow) in the Department of Medicine- Western Precinct, The University of Melbourne and an Adjunct Senior Lecturer, Central Clinical School, Department of Medicine, Monash University. He is a member of the Australian Government’s Pharmaceutical Benefits Advisory Committee and a Council member of the Endocrine Society of Australia. He has clinical research interests in chronic endocrine diseases including diabetes, thyroid disease and osteoporosis.

Dr Natalie Lumsden

Assistant Investigator

Natalie has a research and project management background that has spanned lab bench, to bedside to population health with a focus on better understanding chronic conditions. She completed her PhD within the Department of Pharmacology, Monash University and postdoctoral training at the Institute for Molecular Bioscience-University of Queensland, Department of Pharmacology-University London and the Baker Heart and Diabetes Research Institute. At Western Health she coordinates projects involving multi-disciplinary teams aiming to deliver innovative solutions for chronic disease detection and management”.

Dr Jesse Zanker

Clinical Research Fellow

Jesse is a consultant geriatrician and a PhD candidate with the University of Melbourne and Australian Institute of Musculoskeletal Science, studying sarcopenia. He is a tutor and lecturer with the Melbourne Medical School. Jesse holds an honorary appointment as a geriatrician at Western Health. He also works clinically in rural and regional Victoria, in partnership with general practitioners and other health professionals to provide comprehensive and holistic care to older adults. He is passionate about the independence and quality of life of older adults from all backgrounds, but particularly people from rural areas, those from the LGBTQI community, and those identifying as Aboriginal Australians.

Dr Diana Navarro-Perez

Project Officer

Dr Navarro-Perez (RNutr.) PhD, MSc is a Clinical Research Coordinator and a Project Officer at Australian Institute for Musculoskeletal Sciences (AIMSS), University of Melbourne – Western Health. She completed a PhD at La Trobe University in 2018 working in the Department of Rehabilitation, Nutrition and Sport where she investigated the effect of a novel dietary intervention on cardiometabolic risk factors in overweight and obese subjects. Diana holds a MSc. in Biotechnology and Bioinformatics from La Trobe University. She has ample experience as a Clinical Research Coordinator including Phase I studies with major pharmaceutical companies and Investigator-Initiated trials in a variety of therapeutic areas.

Dr Mary Levidiotis

Medical Educator

Dr Levidiotis, PhD is a graduate of the University of Melbourne. She has been involved in the development and delivery of medical education for healthcare professionals for a substantial part of her career. She commenced her career working in the Medical Departments of a number of pharmaceutical companies in Clinical Research and Medical-Scientific Liaison roles, where her responsibilities included managing international human clinical drug programs, Clinical Research Departments and developing and delivering clinician education programs for drugs in development. In both her pharmaceutical roles and her work for a number of other organizations her work has focused on the development, delivery and evaluation of (continuing professional development) medical education for Medical Specialists, GPs, Nurses and Pharmacists. Mary’s career has provided her with deep knowledge and expertise around adult learning principles and evidence informed medical practice across a range of therapeutic areas and an excellent knowledge of General Practice in Australia.